T 1503/21 (Combination Tablet/ASTRAZENECA) of 29.02.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T150321.20240229
- Date of decision
- 29 February 2024
- Case number
- T 1503/21
- Petition for review of
- -
- Application number
- 10782116.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- IMMEDIATE RELEASE TABLET FORMULATIONS
- Applicant name
- AstraZeneca AB
AstraZeneca UK Limited - Opponent name
- Hoefer & Partner Patentanwälte mbB
STADA Arzneimittel AG
Generics (U.K.) Limited
Galenicum Health S.L.U. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Inventive step - main request, auxiliary requests 1c, 2-6, 11b, 11c, 12-16 (no)
Inventive step - auxiliary request 17 (yes)
Amendments - auxiliary requests 7-9
Amendments - allowable (no)
Amendments - auxiliary request 17
Amendments - allowable (yes)
Claims - clarity
Claims - auxiliary request 17 (yes)
Sufficiency of disclosure - auxiliary reqeust 17 (yes)
Amendment to case - exercise of discretion - Catchword
- -
- Cited cases
- T 1287/14
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside
2. The case is remitted to the opposition division with the order to maintain the patent in amended form based on the claims of the auxiliary request 17 as filed with the reply of the appellants (patent proprietors) on March 2022 and a description to be adapted thereto.